Meta Via announced it raised $10 Million in an initial filing from an offering of $10 Million

May 15, 2025•3 months ago

Amount Raised

$10 Million

CambridgeBiotechnology

Company Information

Company

MetaVia

Location

545 CONCORD AVENUE

Cambridge, Massachusetts, United States

About

MetaVia (Nasdaq: MTVA) is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. The company is currently developing DA-1726 for the treatment of obesity and DA-1241 for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH).

Related People

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Meta Via announced it raised $10 Million in an initial filing from an offering of $10 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information